Speaking this week at BIO CEO, the heads of Septerna, Upstream Bio and Actuate Therapeutics shared lessons from going public ...
These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...
A groundbreaking study in Nature Cardiovascular Research uncovers promising drug targets for heart failure (HF) and its ...
AB-1002 is an investigational gene therapy for the treatment of adults with non-ischemic cardiomyopathy and New York Heart Association (NYHA) Class III heart failure symptoms GenePHIT is a clinical ...
Anthos Therapeutics, based in Cambridge, has a drug in late-stage clinical trials aimed at preventing strokes and blood clots ...
A cardiac surgery and heart failure team at the University of Michigan implanted a novel mechanical heart pump into a patient as part of a clinical trial that will compare it to the only device ...
In recognition of American Heart Month, PDS Health™, a leading dental and medical support organization, is raising awareness about the critical link between oral health and heart health.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback